戻る Agenda
SESSION 2 (CONTINUED): THE PIP LIFECYCLE: PART 1
Session Chair(s)
Janina Karres, PHD
Scientific Officer, Paediatric Medicines Office
European Medicines Agency, Netherlands
Mette Due Theilade Thomsen, PHD
CEO
PIP Adviser, Denmark
- Group work: How to ensure a global paediatric plan
- Group work: Definition of conditions/indications
Speaker(s)
Group work: How to ensure a global paediatric plan
Mette Due Theilade Thomsen, PHD
PIP Adviser, Denmark
CEO
Group work: Definition of conditions / indications
Janina Karres, PHD
European Medicines Agency, Netherlands
Scientific Officer, Paediatric Medicines Office